GATE-301

N/A

Report date: 2022/10/12 16:37:49
NME

Base Information

Drug NameGATE-301
Drug Alias NameGATE-301GATE301
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInsulin-like growth factor binding protein II stimulants
TargetsInsulin-like growth factor binding protein II
Therapy Area/IndicationsNeurodevelopmental DisordersNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGate Neurosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesGate Neurosciences Inc
Inactive CompaniesN/A
Active IndicationsNeurodevelopmental DisordersNerve Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A